Literature DB >> 25352627

Antibiotic-resistant gram-negative bacterial infections in patients with cancer.

Federico Perez1, Javier Adachi2, Robert A Bonomo1.   

Abstract

Patients with cancer are at high risk for infections caused by antibiotic resistant gram-negative bacteria. In this review, we summarize trends among the major pathogens and clinical syndromes associated with antibiotic resistant gram-negative bacterial infection in patients with malignancy, with special attention to carbapenem and expanded-spectrum β-lactam resistance in Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia--all major threats to our cancer patients. Optimal therapy for these antibiotic-resistant pathogens still remains to be determined.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Acinetobacter baumannii; Pseudomonas aeruginosa; carbapenem-resistant Enterobacteriaceae; infections; neutropenia

Mesh：

Substances：

Year:  2014        PMID： 25352627      PMCID： PMC4303050          DOI： 10.1093/cid/ciu612

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  51 in total

1.  Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin.

Authors:  Anucha Apisarnthanarak; Linda M Mundy
Journal:  Int J Antimicrob Agents       Date:  2012-01-10       Impact factor: 5.283

2.  Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy.

Authors:  H Araoka; T Fujii; K Izutsu; M Kimura; A Nishida; K Ishiwata; N Nakano; M Tsuji; H Yamamoto; Y Asano-Mori; N Uchida; A Wake; S Taniguchi; A Yoneyama
Journal:  Transpl Infect Dis       Date:  2012-01-30       Impact factor: 2.228

3.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

4.  P. aeruginosa bloodstream infections among hematological patients: an old or new question?

Authors:  Chiara Cattaneo; F Antoniazzi; S Casari; G Ravizzola; M Gelmi; C Pagani; M D'Adda; E Morello; A Re; E Borlenghi; N Manca; G Rossi
Journal:  Ann Hematol       Date:  2012-02-15       Impact factor: 3.673

5.  In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii.

Authors:  Paul G Higgins; Danuta Stefanik; Malcolm G P Page; Meredith Hackel; Harald Seifert
Journal:  J Antimicrob Chemother       Date:  2012-02-01       Impact factor: 5.790

6.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

7.  Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients.

Authors:  J Cairo; R Hachem; G Rangaraj; B Granwehr; I Raad
Journal:  Clin Microbiol Infect       Date:  2011-05-20       Impact factor: 8.067

8.  Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.

Authors:  Zubair A Qureshi; David L Paterson; Brian A Potoski; Mary C Kilayko; Gabriel Sandovsky; Emilia Sordillo; Bruce Polsky; Jennifer M Adams-Haduch; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

9.  Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.

Authors:  Mario Tumbarello; Pierluigi Viale; Claudio Viscoli; Enrico Maria Trecarichi; Fabio Tumietto; Anna Marchese; Teresa Spanu; Simone Ambretti; Francesca Ginocchio; Francesco Cristini; Angela Raffaella Losito; Sara Tedeschi; Roberto Cauda; Matteo Bassetti
Journal:  Clin Infect Dis       Date:  2012-07-02       Impact factor: 9.079

10.  Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing.

Authors:  Evan S Snitkin; Adrian M Zelazny; Pamela J Thomas; Frida Stock; David K Henderson; Tara N Palmore; Julia A Segre
Journal:  Sci Transl Med       Date:  2012-08-22       Impact factor: 17.956
View more
  30 in total

1.  Biofilm Production Correlating with Multidrug Resistance Among Clinical Isolates of Acinetobacter baumannii.

Authors:  Venkataramana Kandi
Journal:  J Clin Diagn Res       Date:  2015-06-01

Review 2.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

3.  Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.

Authors:  Ruta Petraitiene; Vidmantas Petraitis; Povilas Kavaliauskas; Bo Bo W Maung; Farehin Khan; Ethan Naing; Thein Aung; Vilma Zigmantaite; Ramune Grigaleviciute; Audrius Kucinskas; Rimantas Stakauskas; Benjamin N Georgiades; Chase A Mazur; Joshua A Hayden; Michael J Satlin; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

4.  Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to Aztreonam.

Authors:  Maria F Mojica; Krisztina M Papp-Wallace; Magdalena A Taracila; Melissa D Barnes; Joseph D Rutter; Michael R Jacobs; John J LiPuma; Thomas J Walsh; Alejandro J Vila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

5.  Pattern of Antimicrobial Sensitivity in Microbiologically Documented Infections in Neutropenic Patients with Haematological Malignancies: A single Center Study.

Authors:  Aisha Jamal; Naveena Fatima; Sajjad Shaikh; Bushra Kaleem; Qurratul Ain Rizvi; Uzma Zaidi; Munira Borhany; Tahir Shamsi
Journal:  Indian J Microbiol       Date:  2019-03-04       Impact factor: 2.461

6.  Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patient.

Authors:  Maria F Mojica; Christopher P Ouellette; Amy Leber; M Brian Becknell; Monica I Ardura; Federico Perez; Masako Shimamura; Robert A Bonomo; Samuel L Aitken; Samuel A Shelburne
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

7.  Biolog Phenotype Microarray Is a Tool for the Identification of Multidrug Resistance Efflux Pump Inducers.

Authors:  P Blanco; F Corona; J L Martínez
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

8.  Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Clinical Bacteria Isolated from Patients with Cancer.

Authors:  Ray Hachem; Ruth Reitzel; Kenneth Rolston; Anne-Marie Chaftari; Issam Raad
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 9.  Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?

Authors:  Federico Perez; Nadim G El Chakhtoura; Krisztina M Papp-Wallace; Brigid M Wilson; Robert A Bonomo
Journal:  Expert Opin Pharmacother       Date:  2016-03-09       Impact factor: 3.889

10.  Simple Secondary Amines Inhibit Growth of Gram-Negative Bacteria through Highly Selective Binding to Phenylalanyl-tRNA Synthetase.

Authors:  Vadim Baidin; Tristan W Owens; Michael B Lazarus; Daniel Kahne
Journal:  J Am Chem Soc       Date:  2021-01-07       Impact factor: 15.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.